University of Birmingham – Drug Discovery Facility

The University of Birmingham is committed to being at the vanguard of academic-led drug discovery and the search for the next generation of therapies that will benefit humankind. Recently, the University of Birmingham has invested nearly three quarters of a million pounds to develop a High-Throughput Screening (HTS) facility. The Birmingham Drug Discovery Facility contains a number of cutting-edge technologies required to enable Birmingham scientists to conduct translational science.

Show full profile

Principal Disease Indication(s)

Infectious disease (Tuberculosis, Salmonella, S.aureus), Leukaemia and Lymphoma, HBV


Small molecules


HTS plate reader

Funding sources:

MRC, Wellcome Trust and ERC



Number of Screens / year (any size):


Medicinal Chemistry Follow-up:


Contact Details

Dr Luke Alderwick

Phone:  Tel: +44 (0)121 414 5472

Contact Form

To contact us, please fill in the form below

Getting there

Address: Birmingham, Birmingham, West Midlands B15, UK
- Enter Your Location -
- or -